In solid tumors, tumor cells can express high levels of immune checkpoint molecules, including PD-L1 and PD-L2, to inhibit the effector functions of tumor-infiltrating T cells and CAR-T cells (70). This evidence concerns the gene PDCD1LG2 and neoplasm.